Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity

<div>A male infant born at a gestational age of 27 weeks showed Type 1 ROP at 32 weeks PMA. (a, b) An avascular area was observed and is indicated with yellow arrows. Temporal-sparing LIO combined with IVB was performed. Two weeks after treatment, temporal retinal vessels had reached the laser-treated Zone II area. (c, d) The edge of the vascularized retina is indicated with white arrows. Reactivation of ROP was not observed through 137 weeks of follow-up.</div>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity 

Figure 2 | Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity 